- Home
- CLBT vs ALKS Comparison
CLBT vs ALKS Comparison
Compare CLBT & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBT
- ALKS
- Stock Information
- Founded
- CLBT 1999
- ALKS 1987
- Country
- CLBT Israel
- ALKS Ireland
- Employees
- CLBT N/A
- ALKS N/A
- Industry
- CLBT Computer Software: Prepackaged Software
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- CLBT Technology
- ALKS Health Care
- Exchange
- CLBT Nasdaq
- ALKS Nasdaq
- Market Cap
- CLBT 4.6B
- ALKS 4.5B
- IPO Year
- CLBT N/A
- ALKS 1991
- Fundamental
- Price
- CLBT $19.84
- ALKS $30.13
- Analyst Decision
- CLBT Strong Buy
- ALKS Buy
- Analyst Count
- CLBT 7
- ALKS 12
- Target Price
- CLBT $23.43
- ALKS $38.33
- AVG Volume (30 Days)
- CLBT 816.0K
- ALKS 1.9M
- Earning Date
- CLBT 05-14-2025
- ALKS 05-01-2025
- Dividend Yield
- CLBT N/A
- ALKS N/A
- EPS Growth
- CLBT N/A
- ALKS N/A
- EPS
- CLBT N/A
- ALKS 2.09
- Revenue
- CLBT $401,203,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- CLBT $23.09
- ALKS N/A
- Revenue Next Year
- CLBT $17.61
- ALKS $4.09
- P/E Ratio
- CLBT N/A
- ALKS $14.50
- Revenue Growth
- CLBT 23.41
- ALKS N/A
- 52 Week Low
- CLBT $10.25
- ALKS $22.90
- 52 Week High
- CLBT $26.30
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- CLBT 54.94
- ALKS 51.87
- Support Level
- CLBT $18.78
- ALKS $29.78
- Resistance Level
- CLBT $20.53
- ALKS $31.99
- Average True Range (ATR)
- CLBT 0.55
- ALKS 1.04
- MACD
- CLBT 0.01
- ALKS 0.42
- Stochastic Oscillator
- CLBT 71.01
- ALKS 64.09
About CLBT Cellebrite DI Ltd.
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.